DIABETES Modification of Ghrelin Receptor Signaling by Somatostatin Receptor-5 Regulates Insulin Release The data presented are consistent with physiologically relevant noncanonical ghrelin receptor:somatostatin (SST) receptor subtype 5 heteromerization that explains differential regulation of islet function by ghrelin and SST. These findings reinforce the concept that signaling by the G-protein receptor is dynamic and dependent on protomer interactions and physiological context. [Proc Natl Acad Sci USA] Abstract Ectopic Expression of GIP in Pancreatic β-Cells Maintains Enhanced Insulin Secretion in Mice with Complete Absence of Proglucagon-Derived Peptides Results indicated that ectopic glucose-dependent insulinotropic polypeptide (GIP) expression in β-cells maintains insulin secretion in the absence of proglucagon-derived peptides, revealing a novel compensatory mechanism for sustaining incretin hormone action in islets. [Diabetes] Abstract Nonviral-Mediated Hepatic Expression of IGF-I Increases Regulatory T-Cell Levels and Suppresses Autoimmune Diabetes in Mice Researchers demonstrated that transient, plasmid-derived IGF-I expression in mouse liver suppressed autoimmune diabetes progression. Suppression was associated with decreased islet inflammation and β-cell apoptosis, increased β-cell replication, and normalized β-cell mass. [Diabetes] Abstract Human Blood Outgrowth Endothelial Cells Improve Islet Survival and Function When Co-Transplanted in a Mouse Model of Diabetes The authors evaluated a potentially beneficial effect of adult human blood outgrowth endothelial cells on islet graft vascularization and function. [Diabetologia] Abstract Contribution of 24 Obesity-Associated Genetic Variants to Insulin Resistance, Pancreatic Beta-Cell Function and Type 2 Diabetes Risk in the French Population Investigators aimed at analyzing the effect of 24 obesity risk alleles, separately and in combination, on variation of both insulin resistance and β-cell dysfunction, and on type 2 diabetes risk. [Int J Obesity] Abstract PANCREATIC CANCER Effects of Oxidative Alcohol Metabolism on the Mitochondrial Permeability Transition Pore and Necrosis in a Mouse Model of Alcoholic Pancreatitis Scientists investigated the effects of ethanol on the pancreatic mitochondrial permeability transition pore, the mechanisms of these effects, and their role in pancreatitis. [Gastroenterology] Abstract Inhibition of the Nrf2 Transcription Factor by the Alkaloid Trigonelline Renders Pancreatic Cancer Cells More Susceptible to Apoptosis through Decreased Proteasomal Gene Expression and Proteasome Activity Pancreatic carcinoma cell lines and H6c7 pancreatic duct cells were analyzed for the nuclear factor E2-related factor 2 (Nrf2)-inhibitory effect of the coffee alkaloid trigonelline, as well as for its impact on Nrf2-dependent proteasome activity and resistance to tumor necrosis factor-related apoptosis-inducing ligand and anticancer drug-induced apoptosis. [Oncogene] Abstract MUC1 Enhances Hypoxia-Driven Angiogenesis through the Regulation of Multiple Proangiogenic Factors Using the conditioned medium obtained from hypoxia-stressed AsPC1 cells treated with mucin 1 (MUC1) siRNAs, scientists demonstrated that MUC1 enhanced the endothelial tube formation, proliferation and migration ability, which induced by hypoxia-conditioned medium. In addition, MUC1 was significantly induced by hypoxia, especially in the pancreatic cancer cells derived from metastatic tumors, and MUC1-cytoplasmic tail accumulated in the nucleus under hypoxia. [Oncogene] Abstract Exosomal Lipids Impact Notch Signaling and Induce Death of Human Pancreatic Tumoral SOJ-6 Cells Researchers previously reported that exosomes secreted by human SOJ-6 pancreatic tumor cells induce (glyco)protein ligand-independent cell death and inhibit Notch-1 pathway, this latter being particularly active during carcinogenesis and in cancer stem cells. Therefore, they evaluated whether exosomal lipids were key-elements for cell death and hypothesized that cholesterol-rich membrane microdomains were privileged sites of exosome interactions with tumor cells. [PLoS One] Full Article Gene Therapy of Pancreatic Cancer Targeting the K-Ras Oncogene Ras mutations are present in ~95% of pancreatic cancer cases leading to increased proliferation and apoptosis resistance. The aim of this study was to selectively kill Ras-transformed cells by overexpressing the pro-apoptotic protein, p53 upregulated modulator of apoptosis under a Ras-responsive promoter. [Cancer Gene Ther] Abstract |